Earnings · China A-shares
Shanghai Allist Pharmaceuticals Co. Ltd. Class A (688578) earnings
Shanghai Allist Pharmaceuticals Co. Ltd. Class A published its Q3 report on 2026-10-27: net profit +44.41% year on year, +47.04% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -2.17% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- +44.41%
- Excl. one-offs YoY
- +47.04%
- Net profit QoQ
- -12.41%
- Result
- Good
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -1.82% | — |
| 3 days | -2.17% | — |
| 7 days | +4.83% | — |
| 14 days | -1.50% | — |
Report history
Over the last 8 reports, net profit grew year on year in 8 of them. The stock rose in the 3 trading days after 1 of 6 reports (average -0.04%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥2.33B | +44.41% | +47.04% | +37.57% | 5.19 | 28.65% | -2.17% | — | — |
| 2026 interim report | 2026-08-20 | ¥1.54B | +46.57% | +50.99% | +39.85% | 3.42 | 19.70% | -3.68% | -22.94% | -17.25% |
| 2026 Q1 report | 2026-04-23 | ¥636.04M | +54.94% | +59.86% | +44.19% | 1.41 | 8.59% | -6.76% | -17.84% | -16.29% |
| 2025 annual report | 2026-04-23 | ¥2.19B | +53.10% | +48.54% | +45.80% | 4.86 | 35.40% | -6.76% | -17.84% | -16.29% |
| 2025 Q3 report | 2025-10-29 | ¥1.62B | +52.01% | +43.62% | +47.35% | 3.59 | 27.92% | -5.79% | -13.72% | -10.25% |
| 2025 interim report | 2025-08-27 | ¥1.05B | +60.22% | +39.92% | +50.57% | 2.34 | 18.58% | +19.82% | +11.69% | +7.91% |
| 2025 Q1 report | 2025-04-24 | ¥410.50M | +34.13% | +31.45% | +47.86% | 0.91 | 7.43% | -1.64% | +9.48% | +7.20% |
| 2024 annual report | 2025-04-24 | ¥1.43B | +121.97% | +124.51% | +76.29% | 3.18 | 29.26% | -1.64% | +9.48% | +7.20% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.